Author

K. Ji

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

R. Wang· 2 shared A. Loftus· 1 shared A. Mudigonda· 1 shared A. Roichman· 1 shared A. Vaziri-Gohar· 1 shared B. Zhao· 1 shared C. Boutros· 1 shared C. Dong· 1 shared

Activity by Year

2017-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

R. Wang

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Meis1 isoform diversity orchestrates neural progenitor differentiation by regulating ATOH1 degradation at distinct subcellular compartments

T. Owa, T. Adachi, R. Shiraishi, K. Ichijo, K. Ji, M. Mizuno, K. Suyama, K. Nishitani, I. Hasegawa, M. Sone, D. Kawauchi, T. Nishioka, S. Taya, Y. Suzuki, K. Kaibuchi, , M. Hoshino

The paper identifies functionally antagonistic Meis1 isoforms that regulate ATOH1 degradation through distinct subcellular localization and E3 ligase interactions, affecting neural progenitor differentiation.

PLOS Biology · Jul 13, 2026Peer-reviewedCell Biology

A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism

O. Hajihassani, M. Zarei, A. Roichman, A. Loftus, C. Boutros, J. J. Hue, P. Naji, J. A. Boyer, S. Tahhan, P. Gallagher, W. Beegan, J. Choi, S. Lei, C. Kim, M. Rathore, , J. M. Winter

This study shows that a ketogenic diet enhances the effectiveness of glutamine metabolism inhibitors in pancreatic cancer by increasing tumor reliance on glutamine for energy.

bioRxiv · Jul 19, 2024 · PreprintCancer Biology

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer

E. Lee, S. Archasappawat, K. Ji, J. Pena, V. Fernandez-Vega, R. Gangaraju, N. S. Beesabathuni, M. Kim, Q. Tian, P. Shah, L. Scampavia, T. Spicer, C.-i. Hwang

This study identifies BET inhibition as a potential therapy for BRCA2-deficient pancreatic cancer by showing it enhances autophagy-dependent cell death in these cells.

bioRxiv · May 30, 2023 · PreprintCancer Biology

FGF21 regulates melanogenesis in alpaca melanocytes via ERK1/2-Mediated MITF downregulation

R. Wang, T. Chen, B. Zhao, R. Fan, K. Ji, X. Yu, X. Wang, C. Dong

This study shows FGF21 reduces melanogenesis in alpaca melanocytes by activating ERK1/2 and downregulating MITF, leading to decreased melanin production.

bioRxiv · Jun 7, 2017Cell Biology